BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34007439)

  • 1. Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson's Disease and Other Movement Disorders: A Meta-Analysis.
    Mei YL; Yang J; Wu ZR; Yang Y; Xu YM
    Parkinsons Dis; 2021; 2021():8891874. PubMed ID: 34007439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
    Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
    Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Transcranial Sonography of the Substantia Nigra for Detection of Parkinson's Disease: A Systematic Review and Meta-analysis.
    Tao A; Chen G; Deng Y; Xu R
    Ultrasound Med Biol; 2019 Mar; 45(3):628-641. PubMed ID: 30612821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.
    Heim B; Peball M; Hammermeister J; Djamshidian A; Krismer F; Seppi K
    J Parkinsons Dis; 2022; 12(4):1115-1123. PubMed ID: 35180133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
    Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
    Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating progressive supranuclear palsy from other movement disorders using transcranial sonography: a systematic review and meta-analysis.
    Wen Y; Zhou H; Xia M; Liu Q; Quan H; Fang L
    Neurol Sci; 2024 Feb; 45(2):455-465. PubMed ID: 37819487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease.
    Ambrosius W; Michalak S; Owecki M; Łukasik M; Florczak-Wyspiańska J; Kozubski W
    Folia Morphol (Warsz); 2014 Aug; 73(3):267-71. PubMed ID: 25706660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
    Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
    Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial brain sonography for Parkinsonian syndromes.
    Bor-Seng-Shu E; Paschoal FM; Almeida KJ; De Lima Oliveira M; Nogueira RC; Teixeira MJ; Walter U
    J Neurosurg Sci; 2019 Aug; 63(4):441-449. PubMed ID: 31210040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
    van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of substantia nigra sonography in the differentiation of Parkinson's disease and multiple system atrophy.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Tan YY; Chen SD
    Transl Neurodegener; 2018; 7():15. PubMed ID: 30062008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson's disease: a pilot study from China.
    Chen W; Tan YY; Hu YY; Zhan WW; Wu L; Lou Y; Wang X; Zhou Y; Huang P; Gao Y; Xiao Q; Chen SD
    Transl Neurodegener; 2012 Dec; 1(1):25. PubMed ID: 23267690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis.
    Li DH; He YC; Liu J; Chen SD
    Sci Rep; 2016 Feb; 6():20863. PubMed ID: 26878893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial Brain Sonography in Parkinson's Disease and Other Parkinsonian Disorders: a Hospital Study from Tuzla, Bosnia and Herzegovina.
    Smajlovic D; Ibrahimagic OC
    Med Arch; 2017 Aug; 71(4):261-264. PubMed ID: 28974846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.